PhRMA: More dialogue in Japan to balance innovation, drug pricing
By Kohei Kanayasu
Wednesday, February 8, 2017
TOKYO – Japan's pharmaceutical industry is calling for a more collaborative relationship between government and industry in the face of uncertainties in the country and the possibility of more frequent reviews of drug prices.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.